Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results

详细信息    查看全文

• 作者：Partow Kebriaei¹ ; ^{pkebriaei@mdanderson.org} ; Roland Bassett² ; Genevieve Lyons² ; Ben Valdez¹ ; Celina Ledesma¹ ; Gabriela Rondon¹ ; Betul Oran¹ ; Stefan Ciurea¹ ; Amin Alousi¹ ; Uday Popat¹ ; Krina Patel¹ ; Sairah Ahmed¹ ; Amanda Olson¹ ; Qaiser Bashir¹ ; Nina Shah¹ ; Roy Jones¹ ; David Marin¹ ; Katayoun Rezvani¹ ; Yago Nieto¹ ; Issa Khouri¹ ; Muzaffar Qazilbash¹ ; Chitra Hosing¹ ; Elizabeth Shpall¹ ; Richard E. Champlin¹ ; Borje S. Andersson¹
• 关键词：Acute lymphoblastic leukemia ; Allogeneic hematopoietic stem cell transplantation ; Transplant conditioning regimens
• 刊名：Biology of Blood and Marrow Transplantation
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：23
• 期：2
• 页码：285-292
• 全文大小：1098 K
• 卷排序：23

文摘

Long-term outcomes with use of a radiation-free hematopoietic stem cell transplantation (HSCT) conditioning regimen for acute lymphoblastic leukemia (ALL) were analyzed. Results were comparable to those for radiation-containing regimens. Myeloablative clofarabine plus busulfan is an effective HSCT regimen for adult ALL.